You are viewing a past event. Please visit the meetings homepage for current events.
81st Cold Spring Harbor Laboratory Symposium on Quantitative Biology

Targeting Cancer
June 1 - 5, 2016
Abstract Deadline: March 11, 2016

Organizers:

Scott Lowe, Memorial Sloan Kettering Cancer Center
Kornelia Polyak, Dana Farber Cancer Institute
David Stewart, Cold Spring Harbor Laboratory
Bruce Stillman, Cold Spring Harbor Laboratory
Eileen White, The Rutgers Cancer Institute of New Jersey   


Click for downloadable PDF of the 2016 Symposium poster

We are pleased to host the 81st Cold Spring Harbor Symposium which will focus on Targeting Cancer. Implications of how the underlying science can drive improvements in diagnostic, prognostic and therapeutic approaches will be a major theme throughout the Symposium. 

The Symposium will begin at 7:30 pm on Wednesday June 1st, and end on the evening of Sunday June 5th. The Symposium will include nine oral sessions (invited speakers only) and two poster sessions covering the latest research in diverse areas of cancer research. The annual Dorcas Cummings lecture will be given by Charles Sawyers, Memorial Sloan-Kettering Cancer Center.  Social events throughout the Symposium provide ample opportunity for informal interactions and will include a wine-and-cheese party, a beach picnic, cocktails and banquet, and departure brunch on Monday June 6th.
 

Topics:
  • Cancer Genes and Genomes – genome stability, chromatin, epigenetic regulation, etc
  • Cancer Pathways - signaling pathways, networks etc
  • Tumor Cell Biology – cells of origin, metabolism, autophagy, senescence etc
  • Cancer Growth & Progression – microenvironment, stroma/niche, tumor evolution, metastasis etc
  • Innate & Adaptive immune Responses – inflammation, immunotherapies etc
  • Enabling Technologies (single cell sequencing, imaging, genetic screens, genome editing, organoids etc
Invited Speakers:

Angelika Amon, Massachusetts Institute of Technology
Scott Armstrong, Memorial Sloan-Kettering Cancer Center
Gabriele Bergers, University of California, San Francisco
Joan Brugge, Harvard Medical School
Carlos Caldas, Cambridge Institute, Cancer Research UK
Karen Cichowski, Harvard Medical School/Brigham & Women's Hospital
Susan Clark, Garvan Institute of Medical Research, Australia
Chi Van Dang, University of Pennsylvania
Jeffrey Engelman, Massachusetts General Hospital
Gerard Evan, University of Cambridge, UK
Ronald Evans, Salk Institute for Biological Studies
Douglas Fearon, Cold Spring Harbor Laboratory
Andrew Feinberg, Johns Hopkins University School of Medicine
Daniel Haber, Massachusetts General Hospital
William Hahn, Dana-Farber Cancer Center
Tyler Jacks, David H. Koch Institute for Integratie Cancer Research at MIT
Jos Jonkers, Netherlands Cancer Institute, the Netherlands
Carl June, University of Pennsylvania
Cigall Kadoch, Dana-Farber/Harvard Cancer Center
Raghu Kalluri, University of Texas MD Anderson Cancer Center
William Kaelin, HHMI/Dana-Farber Cancer Institute
Yibin Kang, Princeton University
Anthony Letai,, Dana-Farber Cancer Institute
Scott Lowe, Memorial Sloan-Kettering Cancer Center
Guillermina (Gigi) Lozano, UT MD Anderson Cancer Center
David Lyden, Weill Cornell Medical College of Cornell University
Tak Mak, University of Toronto, Canada
Elaine Mardis, Washington University School of Medicine
Martin McMahon, University of Utah, Huntsman Cancer Institute
Ari Melnick, Weill Cornell Medical College
Sean Morrison, UT Southwestern Medical Center
Benjamin Neel, NYU School of Medicine
Luis Parada, Memorial Sloan-Kettering Cancer Center
Kornelia Polyak, Dana-Farber Cancer Institute
Neal Rosen, Memorial Sloan-Kettering Cancer Center
Michael Sadelain, Memorial Sloan-Kettering Cancer Center
Charles Sawyers, Memorial Sloan-Kettering Cancer Center
Manuel Serrano, Spanish National Cancer Center (CNIO), Spain
Rueben Shaw, Salk Institute for Biological Studies
M. Celeste Simon, University of Pennsylvania Medical School
David Solit, Memorial Sloan-Kettering Cancer Center
Michael Stratton, The Wellcome Trust Sanger Institute, UK
Craig Thompson, Memorial Sloan-Kettering Cancer Center
David Tuveson, Cold Spring Harbor Laboratory
Christopher Vakoc, Cold Spring Harbor Laboratory
Harold Varmus, Weill Cornell Medical College
Karen Vousden, Cancer Research, UK Beatson Institute
Valerie Weaver, University of California, San Francisco
Irving Weissman, Stanford University
Robert Weinberg, Whitehead Institute for Biomedical Research
Eileen White, The Rutgers Cancer Institute of New Jersey
Michael Wigler, Cold Spring Harbor Laboratory

 

We hope to see you at Cold Spring Harbor in early June.

This conference will be supported in part by funds provided by the Laboratory's Corporate Sponsor Program. Partial support provided by Genomic Health and Fluidigm. Limited stipends may be available for students and postdocs submitting abstracts and expressing a need for financial support.

Pricing:

Academic Package $1,575
Graduate/PhD Student Package $1,330
Corporate Package $2,000
Academic/Student No-Housing Package $1,050
Corporate No-Housing Package $1,350

 

We have funds to provide partial scholarships for individuals who are US citizens/permanent residents from minority groups under-represented in the life sciences. Please provide justification in writing to Val Pakaluk and state your financial needs. Preference will be given to those applying who submit abstracts to the meeting.

**Artwork - Robert Delaunay - Circular Forms (Formes circulaires), 1930 Oil on canvas 50 3/4 x 76 3/4 inches (128.9 x 194.9 cm) Solomon R. Guggenheim Museum, New York Solomon R. Guggenheim Founding Collection 49.1184**